Merck Opens New €20 Million Distribution Center in Brazil

Access of new systemic therapies for Genito-urinary cancers in low-middle income countries - Frontiers

Merck CHEManager

High NAD Amounts Slow Growth of Proliferative Cancer Cells

COVID-19 tracker: Omicron variant could cause global surge, WHO says; J&J recipients opt for other boosters

AstronauTx closes £48 million Series A financing to create new treatments for Alzheimer's disease - Biotech start-up company developing new treatments for neurodegenerative conditions based on amplifying the brain's own physiological protective

Merck Opens New €20 Million Distribution Center in Brazil

Merck to Become First Provider to Offer Fully Integrated mRNA Services - New sites at Darmstadt and Hamburg complement Merck's global integrated mRNA service network

7 DHL stations to receive IATA CEIV pharma certifications in 2017

Drug manufacturer Dermapharm invests millions in CORAT Therapeutics - Further development of the SARS-CoV-2 antibody COR-101, which is currently in the clinical phase

Merck KGaA doubles gene therapy capacity with opening of second Carlsbad CDMO facility

New VirusExpress™ Platform - News

We are Merck

Pharma Industry News and Analysis

CHEManager International on LinkedIn: Bachem and Lilly Partner on Oligonucleotide APIs